Breaking News Instant updates and real-time market news.

GE

General Electric

$13.06

-0.37 (-2.76%)

07:03
04/09/18
04/09
07:03
04/09/18
07:03

General Electric is most expensive stock in sector, says JPMorgan

After getting feedback from his research note on Friday, JPMorgan analyst Stephen Tusa put out a new note titled "Yes, GE Is The Most Expensive Stock In the Sector." The analyst has an Underweight rating on shares of General Electric with an $11 price target. The stock closed Friday down 37c to $13.06. He believes any recovery in the company's Power unit will be back end loaded into next decade. Tusa also sees a run rate on free cash flow that is "significantly lower" than the prevailing $1 "bull case narrative." GE is the most expensive stock in the sector, he proclaims.

  • 20

    Apr

GE General Electric
$13.06

-0.37 (-2.76%)

04/03/18
SBSH
04/03/18
NO CHANGE
SBSH
Buy
No news from GE could be considered good news, says Citi
Outside of a potential investment from Warren Buffett's Berkshire Hathaway (BRK.A), "no news" could be viewed as "good news" for General Electric (GE), Citi analyst Andrew Kaplowitz tells investors in a research note. No significant new "issues" have emerged following the announcement of GE's insurance reserves funding plan, nor in the company's annual filing published in late February, Kaplowitz argues. He believes that the more time passes with no significant new issues emerging, the more investors can gain confidence that new management can fully focus on executing a turnaround. Further, he sees "at least three specific areas in which inflections over the coming year could serve as catalysts to changing the narrative:" improving cash generation, asset sale announcements, and potentially inflecting energy end markets. Kaplowitz keeps a Buy rating on shares of General Electric. The stock closed yesterday down 36c to $13.12.
04/03/18
JPMS
04/03/18
NO CHANGE
Target $11
JPMS
Underweight
JPMorgan's Tusa wonders how long GE's rating agencies can stay silent
Despite "material changes" in fundamentals, little progress on asset sales, a lack of "clean numbers," and an SEC investigation, ratings agencies covering General Electric "remain on the sidelines" with their commentary, seemingly giving the company "precious time to work their way out," JPMorgan analyst Stephen Tusa tells investors in a research note. The analyst points out that during the Great Recession, GE was AAA rated while needing a bail-out. "We scratch our heads as to the repeated inertia," Tusa writes. The analyst remains cautious on shares of General Electric saying its fundamentals are worse than expected. Tusa wonders how long the rating agencies "can support a currently unjustified rating." He keeps an Underweight rating on GE shares with an $11 price target. The closed yesterday down 36c to $13.12.
04/03/18
STFL
04/03/18
NO CHANGE
Target $13
STFL
Hold
Stifel cuts GE target to $13, makes 'modest proposal' about pension capping
Stifel analyst Robert McCarthy lowered his FY18 EPS estimate for General Electric to 95c from 98c and reduced his FY19 EPS estimate to $1.05 from $1.10, citing continued challenges at Power, expectations for slower growth across long cycle businesses and material cost inflation challenges. Along with trimming his forecasts, he cut his price target on GE shares to $13 from $15. Additionally, McCarthy made a "modest proposal" that GE management, which he said has recently been "virtue signaling" a change in the accountability culture at the company, should consider capping the pension benefits of its Supplementary Pension Plan for long tenured, senior employees and executive management. The analyst keeps a Hold rating on GE.
04/06/18
JPMS
04/06/18
NO CHANGE
Target $11
JPMS
Underweight
General Electric's 2018 closer to normal than many think, says JPMorgan
JPMorgan analyst Stephen Tusa sees downside risk to estimates for General Electric in the near term. In a fresh research note titled "'Normal' is a Relative Term: A Fresh Look at The GE Power Model," Tusa says his 2018 estimates for GE remain below consensus. Debate continues around the sum-of-the-parts and what could be done to unlock value, Tusa writes. He believes that after nine months in the role, management is likely to have a "better story to tell than the one they told in November the next time we hear from them." GE is already discussing actively with some investors the path forward for improvement off of what is perceived to be depressed operating levels, the analyst reveals. Tusa believes, however, that GE's 2018 is closer to "normal" than many think. The analyst sees support for his Underweight rating on the shares with an $11 price target. General Electric closed yesterday up 15c to $13.43.

TODAY'S FREE FLY STORIES

CREE

Cree

$50.17

-0.11 (-0.22%)

, ZTCOY

ZTE Corp.

$0.00

(0.00%)

08:46
08/15/18
08/15
08:46
08/15/18
08:46
Recommendations
Cree, ZTE Corp. analyst commentary  »

Cree organic growth above…

CREE

Cree

$50.17

-0.11 (-0.22%)

ZTCOY

ZTE Corp.

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Sep

DRYS

DryShips

$4.60

-0.05 (-1.08%)

08:46
08/15/18
08/15
08:46
08/15/18
08:46
Hot Stocks
DryShips announces sale of Panamax drybulk carrier »

DryShips announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

08:46
08/15/18
08/15
08:46
08/15/18
08:46
Conference/Events
The Washington Journal holds a discussion on NAFTA renegotiations & trade policy »

Public Citizen Global…

08:45
08/15/18
08/15
08:45
08/15/18
08:45
General news
U.S. retail sales rose 0.5% in July, with the ex-auto component up 0.6% »

U.S. retail sales rose…

HMNY

Helios and Matheson

$0.05

0.0001 (0.20%)

, ASHR

X-trackers Harvest CSI 300

$24.87

(0.00%)

08:45
08/15/18
08/15
08:45
08/15/18
08:45
Options
Largest borrow rate increases among liquid names »

Latest data shows the…

HMNY

Helios and Matheson

$0.05

0.0001 (0.20%)

ASHR

X-trackers Harvest CSI 300

$24.87

(0.00%)

JNK

SPDR Barclays High Yield Bond

$35.86

0.065 (0.18%)

IRBT

iRobot

$87.83

1.72 (2.00%)

ENB

Enbridge

$35.51

0.3108 (0.88%)

WLL

Whiting Petroleum

$48.18

1.73 (3.72%)

HEAR

Turtle Beach

$26.80

-1.15 (-4.11%)

AMJ

American Medical Laboratories Inc

$29.11

0.2 (0.69%)

UCO

Universal Compression

$29.37

-0.06 (-0.20%)

GOGO

Gogo

$4.42

0.05 (1.14%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Aug

  • 20

    Aug

  • 04

    Sep

  • 05

    Sep

  • 06

    Sep

  • 13

    Sep

08:45
08/15/18
08/15
08:45
08/15/18
08:45
General news
FX Action: The dollar »

FX Action: The dollar…

08:45
08/15/18
08/15
08:45
08/15/18
08:45
General news
U.S. Empire State manufacturing index bounced 3 points to 25.6 in August »

U.S. Empire State…

08:42
08/15/18
08/15
08:42
08/15/18
08:42
Conference/Events
RBC Capital to hold a conference »

Consumer Investor Day…

08:41
08/15/18
08/15
08:41
08/15/18
08:41
Conference/Events
Stephens to hold a field trip »

Building Products…

BKH

Black Hills

$60.23

0.235 (0.39%)

, GGG

Graco

$46.02

0.025 (0.05%)

08:40
08/15/18
08/15
08:40
08/15/18
08:40
Conference/Events
CFA Society of Minnesota to hold a conference »

7th Annual Investor…

BKH

Black Hills

$60.23

0.235 (0.39%)

GGG

Graco

$46.02

0.025 (0.05%)

CLFD

Clearfield

$13.05

0.35 (2.76%)

CYBE

Cyberoptics

$19.25

0.05 (0.26%)

CHRW

C.H. Robinson

$93.98

0.02 (0.02%)

DAKT

Daktronics

$8.43

0.02 (0.24%)

CBZ

CBIZ

$22.93

0.275 (1.21%)

DGII

Digi International

$12.95

-0.025 (-0.19%)

PII

Polaris Industries

$107.72

0.42 (0.39%)

ASV

ASV Holdings

$6.28

-0.27 (-4.12%)

ALE

Allete

$77.99

0.97 (1.26%)

DOC

Physicians Realty Trust

$16.83

0.22 (1.32%)

APOG

Apogee Enterprises

$49.74

0.55 (1.12%)

MOS

Mosaic

$30.63

0.25 (0.82%)

DCI

Donaldson

$47.69

0.88 (1.88%)

SRDX

Surmodics

$73.05

2.1 (2.96%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Aug

  • 15

    Aug

  • 21

    Aug

  • 21

    Aug

  • 22

    Aug

  • 26

    Aug

  • 06

    Sep

  • 06

    Sep

  • 29

    Oct

  • 06

    Nov

SHLX

Shell Midstream

$22.73

0.35 (1.56%)

08:39
08/15/18
08/15
08:39
08/15/18
08:39
Hot Stocks
Shell Midstream joint venture Zydeco announces binding open season »

Zydeco, jointly owned by…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KMG

KMG Chemicals

$66.78

0.1 (0.15%)

08:37
08/15/18
08/15
08:37
08/15/18
08:37
Hot Stocks
Breaking Hot Stocks news story on KMG Chemicals »

KMG Chemicals trading…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LULU

Lululemon

$129.47

-0.67 (-0.51%)

08:36
08/15/18
08/15
08:36
08/15/18
08:36
Recommendations
Lululemon analyst commentary  »

Lululemon price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Sep

IDXG

Interpace Diagnostics

$1.03

-0.01 (-0.96%)

08:36
08/15/18
08/15
08:36
08/15/18
08:36
Hot Stocks
Interpace Diagnostics acquires assets of Rosetta Genomics out of bankruptcy »

Interpace Diagnostics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HD

Home Depot

$193.08

-1.03 (-0.53%)

08:34
08/15/18
08/15
08:34
08/15/18
08:34
Recommendations
Home Depot analyst commentary  »

Stifel sees 'no…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CVM

CEL-SCI

$1.03

(0.00%)

08:33
08/15/18
08/15
08:33
08/15/18
08:33
Hot Stocks
CEL-SCI says IDMC recommends continuation of Phase 3 head and neck cancer study »

CEL-SCI announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

08:33
08/15/18
08/15
08:33
08/15/18
08:33
General news
Empire State Mfg Survey General Business Conditions Index data reported »

August Empire State Mfg…

CE

Celanese

$116.73

0.7 (0.60%)

08:32
08/15/18
08/15
08:32
08/15/18
08:32
Hot Stocks
Celanese granted four new patents for Sunett sweetner »

Celanese Corporation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Sep

CYTX

Cytori Therapeutics

$0.40

0.015 (3.95%)

08:32
08/15/18
08/15
08:32
08/15/18
08:32
Downgrade
Cytori Therapeutics rating change  »

Cytori Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KMG

KMG Chemicals

$66.78

0.1 (0.15%)

, CCMP

Cabot Microelectronics

$121.32

0.1 (0.08%)

08:31
08/15/18
08/15
08:31
08/15/18
08:31
Conference/Events
Cabot Microelectronics to hold a conference call »

Conference call to…

KMG

KMG Chemicals

$66.78

0.1 (0.15%)

CCMP

Cabot Microelectronics

$121.32

0.1 (0.08%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Aug

  • 22

    Aug

  • 11

    Sep

TPR

Tapestry

$53.12

5.7 (12.02%)

08:31
08/15/18
08/15
08:31
08/15/18
08:31
Recommendations
Tapestry analyst commentary  »

Tapestry price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Sep

CCMP

Cabot Microelectronics

$121.32

0.1 (0.08%)

, KMG

KMG Chemicals

$66.78

0.1 (0.15%)

08:30
08/15/18
08/15
08:30
08/15/18
08:30
Hot Stocks
Cabot Microelectronics to acquire KMG Chemicals for $1.6B »

Cabot Microelectronics…

CCMP

Cabot Microelectronics

$121.32

0.1 (0.08%)

KMG

KMG Chemicals

$66.78

0.1 (0.15%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Aug

  • 22

    Aug

  • 11

    Sep

ASRT

Assertio Therapeutics

$7.31

0.135 (1.88%)

, JNP

Juniper Pharmaceuticals

$11.50

(0.00%)

08:30
08/15/18
08/15
08:30
08/15/18
08:30
Options
One new option listing and three option delistings on August 15th »

New option listings for…

ASRT

Assertio Therapeutics

$7.31

0.135 (1.88%)

JNP

Juniper Pharmaceuticals

$11.50

(0.00%)

XPLR

Xplore Technologies

$5.99

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

STIM

Neuronetics

$32.28

-1.72 (-5.06%)

08:28
08/15/18
08/15
08:28
08/15/18
08:28
Recommendations
Neuronetics analyst commentary  »

Neuronetics price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TNC

Tennant

$76.60

-0.85 (-1.10%)

08:28
08/15/18
08/15
08:28
08/15/18
08:28
Conference/Events
Tennant management to meet with Oppenheimer »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Aug

  • 22

    Aug

  • 06

    Sep

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.